Overview

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether KAI-1678 is effective in the treatment of pain associated with spinal cord injury.
Phase:
Phase 2
Details
Lead Sponsor:
KAI Pharmaceuticals
Collaborator:
Trident Clinical Research Pty Ltd